AI Article Synopsis
- The study aimed to analyze characteristics of healthy children with obstructive sleep apnea (OSA-I) and those with OSA and non-syndromic obesity (OSA-II) in France who were treated with CPAP or NIV in 2019.
- Data from a national survey focused on CPAP/NIV initiation criteria, duration, age at initiation, equipment used, settings, and compliance were examined.
- Results showed that OSA-II patients were older at initiation and treated longer than OSA-I patients, with both groups mainly using CPAP, but having similar compliance rates.
Article Abstract
Purpose: The aim of the study was to analyze the characteristics of otherwise healthy children with obstructive sleep apnea (OSA; OSA-I) and children with OSA and non-syndromic obesity (OSA-II) treated with long term continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV) in 2019 in France.
Methods: Data were collected from a national survey on paediatric home noninvasive ventilatory support. CPAP/NIV initiation criteria and duration, age at CPAP/NIV initiation, equipment used and CPAP/NIV settings, and objective compliance were analyzed.
Results: Patients with OSA-I and OSA-II represented 6 % (n = 84, 71 % males) and 10 % (n = 144, 72 % males) of the national cohort, respectively. The apnea-hypopnea index (63 % vs 76 %), alone or combined with nocturnal gas exchange (25 % vs 21 %, for OSA-II and OSA-I patients respectively) were used as initiation criteria of CPAP/NIV. OSA-II patients were older at CPAP/NIV initiation (mean age 11.0 ± 4.0 vs 6.8 ± 4.5 years, p < 0.001) and were treated for a longer time (2.3 ± 2.6 vs 1.3 ± 1.5 years, p = 0.008) than OSA-I patients. NIV was used in 6 % of OSA-I patients and 13 % of OSA-II patients (p = 0.142). Both groups used preferentially a nasal mask. Mean CPAP level was higher in OSA-II patients as compared to OSA-I patients (8.7 ± 2.0 vs 7.7 ± 2.4 cmHO, p = 0.02). Objective compliance was comparable (mean use 6.8 ± 2.6 vs 5.9 ± 3.0 h/night in OSA-I and OSA-II, respectively, p = 0.054).
Conclusion: Six and 10 % of children treated with long term CPAP/NIV in France in 2019 had OSA-I and OSA-II, respectively. Both groups were preferentially treated with CPAP and were comparable except for age, with OSA-II patients being older at CPAP/NIV initiation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.sleep.2024.11.039 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long term noninvasive respiratory support in children with OSA-I and OSA-II: Data of a nation-wide study.
Sleep Med
November 2024
Pediatric Noninvasive Ventilation and Sleep Unit, AP-HP, Hôpital Necker-Enfants Malades, F-75015, Paris, France; Université de Paris Cité, EA 7330 VIFASOM, F-75004, Paris, France. Electronic address:
Article Synopsis
- The study aimed to analyze characteristics of healthy children with obstructive sleep apnea (OSA-I) and those with OSA and non-syndromic obesity (OSA-II) in France who were treated with CPAP or NIV in 2019.
- Data from a national survey focused on CPAP/NIV initiation criteria, duration, age at initiation, equipment used, settings, and compliance were examined.
- Results showed that OSA-II patients were older at initiation and treated longer than OSA-I patients, with both groups mainly using CPAP, but having similar compliance rates.
Oxygen therapy and noninvasive respiratory supports in acute hypoxemic respiratory failure: a narrative review.
Ann Intensive Care
October 2024
Assistance Publique - Hôpitaux de Paris, Hôpital Cochin, Service des Urgences, Université Paris-Cité, Paris, France.
Background: This narrative review was written by an expert panel to the members of the jury to help in the development of clinical practice guidelines on oxygen therapy.
Results: According to the expert panel, acute hypoxemic respiratory failure was defined as PaO < 60 mm Hg or SpO < 90% on room air, or PaO/FiO ≤ 300 mm Hg. Supplemental oxygen should be administered according to the monitoring of SpO, with the aim at maintaining SpO above 92% and below 98%.
Noninvasive Ventilation or CPAP in the Initial Treatment Phase of Small Infants With Respiratory Failure.
Respir Care
July 2024
Division of Pediatric Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.
Background: Respiratory failure in infants is a common reason for admission to the pediatric ICU (PICU). Although high-flow nasal cannula (HFNC) is the preferred first-line treatment at our institution, some infants require CPAP or noninvasive ventilation (NIV). Here we report our experience using CPAP/NIV in infants < 10 kg.
View Article and Find Full Text PDFPediatric long-term noninvasive respiratory support in children with central nervous system disorders.
Pediatr Pulmonol
March 2024
Department of Pediatric Pulmonology, AP-HP, Hôpital Armand Trousseau, Paris, France.
Rationale: The use of long-term noninvasive respiratory support is increasing in children along with an extension of indications, in particular in children with central nervous system (CNS) disorders.
Objective: The aim of this study was to describe the characteristics of children with CNS disorders treated with long-term noninvasive respiratory support in France.
Methods: Data were collected from 27 French pediatric university centers through an anonymous questionnaire filled for every child treated with noninvasive ventilatory support ≥3 months on 1st June 2019.
Detection of Simulated Pediatric Breathing by CPAP/Noninvasive Ventilation Devices.
Respir Care
August 2023
Pediatric Sleep and Noninvasive Ventilation Unit, AP-HP Necker Hospital, Paris, France; Université Paris Cité, VIFASOM, Paris, France; and ASV Santé, Gennevilliers, France.
Article Synopsis
- Home CPAP and noninvasive ventilation (NIV) are becoming more common for children, but not all devices provide accurate patient data, prompting a study on tidal volume (V) detection rather than weight.
- The study tested twelve CPAP devices to see how well they detected various simulated pediatric tidal volumes, revealing a range of detection from 16 to 84 mL among devices regardless of their level classification.
- Results showed that level I devices generally underestimated CPAP use duration and struggled with waveform displays, while level II and III devices overestimated use and provided more consistent waveforms when turned on.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!